1. Home
  2. AEYE vs ZNTL Comparison

AEYE vs ZNTL Comparison

Compare AEYE & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEYE
  • ZNTL
  • Stock Information
  • Founded
  • AEYE 2005
  • ZNTL 2014
  • Country
  • AEYE United States
  • ZNTL United States
  • Employees
  • AEYE N/A
  • ZNTL N/A
  • Industry
  • AEYE Computer Software: Prepackaged Software
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEYE Technology
  • ZNTL Health Care
  • Exchange
  • AEYE Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • AEYE 278.0M
  • ZNTL 273.1M
  • IPO Year
  • AEYE N/A
  • ZNTL 2020
  • Fundamental
  • Price
  • AEYE $25.51
  • ZNTL $3.47
  • Analyst Decision
  • AEYE Strong Buy
  • ZNTL Buy
  • Analyst Count
  • AEYE 4
  • ZNTL 8
  • Target Price
  • AEYE $30.13
  • ZNTL $10.50
  • AVG Volume (30 Days)
  • AEYE 221.5K
  • ZNTL 1.6M
  • Earning Date
  • AEYE 11-07-2024
  • ZNTL 11-12-2024
  • Dividend Yield
  • AEYE N/A
  • ZNTL N/A
  • EPS Growth
  • AEYE N/A
  • ZNTL N/A
  • EPS
  • AEYE N/A
  • ZNTL N/A
  • Revenue
  • AEYE $33,348,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • AEYE $13.79
  • ZNTL N/A
  • Revenue Next Year
  • AEYE $18.88
  • ZNTL N/A
  • P/E Ratio
  • AEYE N/A
  • ZNTL N/A
  • Revenue Growth
  • AEYE 6.94
  • ZNTL N/A
  • 52 Week Low
  • AEYE $3.97
  • ZNTL $2.66
  • 52 Week High
  • AEYE $34.85
  • ZNTL $18.07
  • Technical
  • Relative Strength Index (RSI)
  • AEYE 50.81
  • ZNTL 49.60
  • Support Level
  • AEYE $23.99
  • ZNTL $3.65
  • Resistance Level
  • AEYE $34.85
  • ZNTL $4.44
  • Average True Range (ATR)
  • AEYE 2.50
  • ZNTL 0.42
  • MACD
  • AEYE 0.15
  • ZNTL 0.04
  • Stochastic Oscillator
  • AEYE 32.76
  • ZNTL 45.51

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: